UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 857

Sortiert nach

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota

Cell metabolism, 2018-06, Vol.27 (6), p.1222-1235.e6

2018

Volltextzugriff (PDF)

A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms

Cell reports (Cambridge), 2016-06, Vol.15 (10), p.2136-2146

2016

Volltextzugriff (PDF)

Effects of dietary restriction on neuroinflammation in neurodegenerative diseases

The Journal of experimental medicine, 2021-02, Vol.218 (2)

2021

Volltextzugriff (PDF)

Ofatumumab versus Teriflunomide in Multiple Sclerosis

The New England journal of medicine, 2020-08, Vol.383 (6), p.546-557

2020

Volltextzugriff (PDF)

Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice

Neurology, 2019-01, Vol.92 (1), p.26

2019

Volltextzugriff (PDF)

Can CSF biomarkers predict future MS disease activity and severity?

Multiple sclerosis, 2020-04, Vol.26 (5), p.582-590

2020

Volltextzugriff (PDF)

MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis

Journal of neuroimmunology, 2022-10, Vol.371, p.577935-577935, Article 577935

2022

Volltextzugriff (PDF)

Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion

Neurologic clinics, 2024-02, Vol.42 (1), p.137-153

2024

Volltextzugriff (PDF)

Axial Diffusivity Is the Primary Correlate of Axonal Injury in the Experimental Autoimmune Encephalomyelitis Spinal Cord: A Quantitative Pixelwise Analysis

The Journal of neuroscience, 2009-03, Vol.29 (9), p.2805-2813

2009

Volltextzugriff (PDF)

Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?

JAMA neurology, 2023-07, Vol.80 (7), p.669

2023

Volltextzugriff (PDF)

Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis

Journal of leukocyte biology, 2008-10, Vol.84 (4), p.940-948

2008

Volltextzugriff (PDF)

Quantification of increased cellularity during inflammatory demyelination

Brain (London, England : 1878), 2011-12, Vol.134 (12), p.3587-3598

2011

Volltextzugriff (PDF)

Further support for rituximab in relapsing multiple sclerosis

Lancet neurology, 2022-08, Vol.21 (8), p.672-673

2022

Volltextzugriff (PDF)

TREM2 regulates microglial cell activation in response to demyelination in vivo

Acta neuropathologica, 2015-03, Vol.129 (3), p.429-447

2015

Volltextzugriff (PDF)

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis

Frontiers in neurology, 2021-01, Vol.11, p.595547-595547

2021

Volltextzugriff (PDF)

MS treatment de-escalation: review and commentary

Journal of neurology, 2024-08

2024

Volltextzugriff (PDF)

Limbic system damage in MS: MRI assessment and correlations with clinical testing

PloS one, 2017-11, Vol.12 (11), p.e0187915-e0187915

2017

Volltextzugriff (PDF)

a new imaging modality to non-invasively assess multiple sclerosis pathology

Journal of neuroimmunology, 2017-03, Vol.304, p.81-85

2017

Volltextzugriff (PDF)

Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity

JAMA neurology, 2016-02, Vol.73 (2), p.219

2016

Volltextzugriff (PDF)

Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241241383-17562864241241383

2024

Volltextzugriff (PDF)

Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema

NeuroImage (Orlando, Fla.), 2014-11, Vol.101, p.310-319

2014

Volltextzugriff (PDF)

On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI

Magnetic resonance in medicine, 2015-01, Vol.73 (1), p.195-203

2015

Volltextzugriff (PDF)

Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis

European Journal of Immunology, 2007-05, Vol.37 (5), p.1290-1301

2007

Volltextzugriff (PDF)

Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis

Brain (London, England : 1878), 2015-05, Vol.138 (Pt 5), p.1223-1238

2015

Volltextzugriff (PDF)

Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis

Journal of magnetic resonance imaging, 2019-02, Vol.49 (2), p.487-498

2019

Volltextzugriff (PDF)

1 – 25 von 857

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(748)
Mit Volltextzugriff
(739)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota

A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms

Effects of dietary restriction on neuroinflammation in neurodegenerative diseases

Ofatumumab versus Teriflunomide in Multiple Sclerosis

Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice

Can CSF biomarkers predict future MS disease activity and severity?

MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis

Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion

Axial Diffusivity Is the Primary Correlate of Axonal Injury in the Experimental Autoimmune Encephalomyelitis Spinal Cord: A Quantitative Pixelwise Analysis

Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?

Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis

Quantification of increased cellularity during inflammatory demyelination

Further support for rituximab in relapsing multiple sclerosis

TREM2 regulates microglial cell activation in response to demyelination in vivo

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis

MS treatment de-escalation: review and commentary

Limbic system damage in MS: MRI assessment and correlations with clinical testing

a new imaging modality to non-invasively assess multiple sclerosis pathology

Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity

Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema

On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI

Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis

Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis

Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis

Suchergebnisse filtern